Table 2.
Quality assessment of included clinical studies using PEDro.
| Study | Random allocation | Concealed allocation | Baseline comparability | Blind subjects | Blind therapists | Blind assessors | Adequate follow-up | Intention-to-treat analysis | Between group comparisons | Point estimates and variability | Total Scores |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Khurana et al. (60) (ImpACT-1) | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5/10 |
| Bornstein 2019 (ImpACT-24A) (61) | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 7/10 |
| Bornstein 2019 (ImpACT-24B) (62) | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 7/10 |
| Saver et al. (ImpACT-24M) (63) | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5/10 |
| Sanchez et al. (52) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 4/10 |